BRPI0412451A - agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável - Google Patents

agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável

Info

Publication number
BRPI0412451A
BRPI0412451A BRPI0412451-0A BRPI0412451A BRPI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A BR PI0412451 A BRPI0412451 A BR PI0412451A
Authority
BR
Brazil
Prior art keywords
treatment
prophylaxis
agonists
irritable bowel
bowel syndrome
Prior art date
Application number
BRPI0412451-0A
Other languages
English (en)
Inventor
Wolfgang Stohle
Rudolf Gottschlich
Juergen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0412451A publication Critical patent/BRPI0412451A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"AGONISTAS CAPA EM PARTICULAR PARA O TRATAMENTO E/OU A PROFILAXIA DA SìNDROME DO INTESTINO IRRITáVEL". A presente invenção refere-se a composto da fórmula (I), onde A, R¬ 1¬, R¬ 2¬, R¬ 3¬, X, Y, m e n têm os significados indicados, são adequados para o tratamento da síndrome do intestino Irritável.
BRPI0412451-0A 2003-07-11 2004-06-18 agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável BRPI0412451A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10331723A DE10331723A1 (de) 2003-07-11 2003-07-11 Kappa-Agonisten
PCT/EP2004/006630 WO2005007626A1 (de) 2003-07-11 2004-06-18 Kappa-agonisten insbesondere zur behandlung und/ oder prophylaxe des irritable bowel syndroms

Publications (1)

Publication Number Publication Date
BRPI0412451A true BRPI0412451A (pt) 2006-09-19

Family

ID=34071646

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412451-0A BRPI0412451A (pt) 2003-07-11 2004-06-18 agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável

Country Status (14)

Country Link
US (1) US20060178426A1 (pt)
EP (1) EP1644327A1 (pt)
JP (1) JP2007506677A (pt)
KR (1) KR20060030895A (pt)
CN (1) CN1819994A (pt)
AR (1) AR046153A1 (pt)
AU (1) AU2004256892A1 (pt)
BR (1) BRPI0412451A (pt)
CA (1) CA2531817A1 (pt)
DE (1) DE10331723A1 (pt)
MX (1) MXPA06000366A (pt)
RU (1) RU2006104024A (pt)
WO (1) WO2005007626A1 (pt)
ZA (1) ZA200601228B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20100221329A1 (en) 2008-12-03 2010-09-02 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
US9815824B2 (en) 2013-06-28 2017-11-14 Nektar Therapeutics Kappa opioid agonists and uses thereof
WO2015042071A1 (en) * 2013-09-19 2015-03-26 Allergan, Inc. Diphenyl urea derivatives as formyl peptide receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
AU7133098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Kappa opioid agonists
DE19849650A1 (de) * 1998-10-29 2000-05-04 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung des Irritable Bowel Syndroms (IBS)

Also Published As

Publication number Publication date
AU2004256892A1 (en) 2005-01-27
RU2006104024A (ru) 2006-07-27
CN1819994A (zh) 2006-08-16
DE10331723A1 (de) 2005-06-16
ZA200601228B (en) 2007-05-30
EP1644327A1 (de) 2006-04-12
MXPA06000366A (es) 2006-03-28
AR046153A1 (es) 2005-11-30
KR20060030895A (ko) 2006-04-11
JP2007506677A (ja) 2007-03-22
CA2531817A1 (en) 2005-01-27
US20060178426A1 (en) 2006-08-10
WO2005007626A1 (de) 2005-01-27

Similar Documents

Publication Publication Date Title
CY1110498T1 (el) Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
ATE484508T1 (de) Furylverbindungen
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
DE60333746D1 (de) Thienylverbindungen
BRPI0412451A (pt) agonistas capa em particular para o tratamento e/ou a profilaxia da sìndrome do intestino irritável
BR0200782A (pt) Compostos para o tratamento da isquemia
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
BRPI0410630A (pt) antagonista de nk1
NO20044995L (no) Heterosykliske forbindelser
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
BRPI0416690A (pt) derivados de pirrol
BRPI0514841A (pt) inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores
EA200001133A1 (ru) Антипикорнавирусные композиции, их получение и применение
BR0308606A (pt) Derivados de hemiasterlina e usos destes
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
BRPI0416156A (pt) uso de tienopirimidinas
ATE553077T1 (de) Peptidaseinhibitoren
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
BRPI0412862A (pt) derivados da nicotinamida úteis como inibidores de pde4
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
BRPI0415285A (pt) derivados de aminoalcanol
BRPI0417153A (pt) derivados de carboxamida
BRPI0415355A (pt) triarilimidazóis

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]